BioLineRx (BLRX) Issued US Patent Covering BL-8040 to Obtain Stem Cells – StreetInsider.com (subscription)
|
BioLineRx (BLRX) Issued US Patent Covering BL-8040 to Obtain Stem Cells
StreetInsider.com (subscription) BioLineRx (Nasdaq: BLRX) announced that an Issue Notification has been received from the United States Patent and Trademark Office (USPTO) for US Patent No. 8,455,450, which claims the use of BL-8040’s composition for obtaining hematopoietic … |
